Aldeyra Therapeutics (NASDAQ:ALDX) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Aldeyra Therapeutics (NASDAQ:ALDX – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the biotechnology company’s stock. A number of other research analysts also recently weighed in on the company. Citigroup increased their target price on Aldeyra Therapeutics from […]